Biogen (NASDAQ:BIIB – Free Report) had its price target decreased by BMO Capital Markets from $156.00 to $139.00 in a report ...
DuPont de Nemours (NYSE:DD – Free Report) had its price target raised by BMO Capital Markets from $105.00 to $112.00 in a ...
RBC Capital analyst Ben Hendrix raised the firm’s price target on CVS Health (CVS) to $74 from $58 and keeps an Outperform ...
A coffee shop that’s also a branch of one of the nation’s biggest banks is among the new retail options at a St. Louis-area ...